Why Did The Cogstate (ASX: CGS) Share Price Crash?
The Cogstate share price plunged after takeover discussions ceased. Then came a trading halt, a guidance cut, and another share price plunge.
The Cogstate share price plunged after takeover discussions ceased. Then came a trading halt, a guidance cut, and another share price plunge.
The Cogstate share price is up today because of favourable clinical trial results from its partner Eisai. Why does it matter?
Cogstate (ASX: CGS), Pureprofile (ASX: PPL) and Genetic Signatures (ASX: GSS) each recently updated the market on Q3 FY 2022 results.
The recent approval of Eisai’s Aduhelm has got the market’s attention, because it translates into higher profits for Cogstate.
Some stocks have high multiples and higher growth rates, others have lower multiples and lower growth rates. Here’s how I decided which one to choose.